Ultime notizie per Viking Holdings (NYSE:VIK) Azioni

Viking Holdings

Viking Holdings Ltd is a travel company, with a fleet of 92 small, state-of-the-art ships, which view as floating hotels. It offer travel experiences on all seven continents in all three categories of the cruise industry—river, ocean and expedition cruising. The Group defines its products based on the type of cruise offering and language of the cruise service. The River segment provides river cruises outside the United States to English-speaking passengers. The Ocean segment provides ocean cruises to English-speaking passengers. Other includes operating segments that are not individually reportable, consisting of expedition cruises for English-speaking passengers ("Expedition"), Mississippi River cruises for English-speaking passengers, Viking China, which includes cruises for Mandarin.

Viking Holdings Ltd

VIKASA SPAC Series I Acquisition Corp

VIKING THERAPEUTICS ORD

Viking Energy Group Inc

Viking Line Abp

Viking Therapeutics Inc

WIIM

FIVN

Five9 shares are trading higher after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $35 to $46. Needham also reiterated its Buy rating.

Benchmark analyst Mark Miller maintains Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Buy and raises the price target from $240 to $245.

News

Price Target

Analyst Ratings

NVMI

Benchmark Maintains Buy on Nova, Raises Price Target to $245

Earnings

CRESY

CRESUD S.A.C.I.F. y A. Q1 2025 EPS ARS(66.54) Vs ARS181.95 YoY

UPST

Upstart Holdings shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $31 to $85. Citigroup upgraded the stock from Neutral to Buy and raised its price target from $56 to $87.

Truist Securities analyst William Stein maintains Diodes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIOD#NASDAQ">DIOD</a>) with a Hold and lowers the price target from $69 to $62.

DIOD

Truist Securities Maintains Hold on Diodes, Lowers Price Target to $62

Evolent Health shares are trading lower after Stephens & Co. downgraded the stock from Overweight to Equal-Weight and announced a price target of $16.

Benchmark analyst Mike Hickey maintains Sportradar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) with a Buy and raises the price target from $14 to $16.

SRAD

Benchmark Maintains Buy on Sportradar Gr, Raises Price Target to $16

Truist Securities analyst Keith Hughes maintains CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) with a Buy and raises the price target from $110 to $120.

Truist Securities Maintains Buy on CRH, Raises Price Target to $120

Scotiabank analyst Andres Coello maintains Liberty Latin America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILAK#NASDAQ">LILAK</a>) with a Sector Outperform and lowers the price target from $9.4 to $8.3.

LILAK

Scotiabank Maintains Sector Outperform on Liberty Latin America, Lowers Price Target to $8.3

Taiwan Semiconductor Manufacturing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) said that its investment strategy in the United States remains unaffected despite Donald Trump&#8217;s recent election win.
The statement came after speculation about potential changes to its plans following Trump&#8217;s critical remarks on Taiwan&#8217;s semiconductor industry, SCMP <a target="_blank" href="https://www.scmp.com/tech/policy/article/3285673/taiwans-chipmaker-tsmc-says-us-investment-plan-unchanged-after-trumps-election?module=perpetual_scroll_0&amp;pgtype=article" rel="noreferrer noopener">reports</a>.
Taiwan Semiconductor, a major supplier to tech giants like Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), is proceeding with its $65 billion investment in advanced semiconductor production facilities in Arizona.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41820580/applovins-high-valuation-and-expansion-beyond-gaming-prompt-analyst-caution" rel="noreferrer noopener">AppLovin&#8217;s High Valuation and Expansion Beyond Gaming Prompt Analyst Caution</a>
Throughout his campaign, Trump accused Taiwan <a target="_blank" href="https://www.benzinga.com/news/24/11/41780976/chip-stocks-like-nvidia-broadcom-taiwan-semi-gain-after-trump-win-whats-going-on" rel="noreferrer noopener">of undermining the</a> U.S. chip industry.
In a podcast appearance last month, he criticized the Chips Act, labeling it &#8220;a poor strategy,&#8221; suggesting tariffs would have been a more practical approach than offering subsidies to wealthy corporations.
The Biden administration recently notified Congress about imminent <a target="_blank" href="https://www.benzinga.com/government/24/11/41811866/taiwan-semi-and-globalfoundries-finalize-major-us-funding-deals-eye-growth-in-chip-manufacturing" rel="noreferrer noopener">awards from the</a> Chips Act, expected to benefit Taiwan Semiconductor, GlobalFoundries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>), and a third unnamed semiconductor company.
The Act incentivizes chipmakers to expand U.S. production, allocating $37 billion across 21 preliminary agreements.
Despite concerns over Trump&#8217;s criticism of the Chips Act, Taiwan Semiconductor&#8217;s stock has shown resilience. The stock gained further momentum following a surge in Nvidia&#8217;s share price.
Taiwan Semiconductor has notified its clients in mainland China that it will cease production of advanced chips for them. The decision affects customers seeking chip designs using 7-nanometer technology or smaller, SCMP <a target="_blank" href="https://www.scmp.com/tech/tech-war/article/3285805/tsmc-halts-advanced-chip-orders-mainland-china-after-us-export-curbs-evasion-source" rel="noreferrer noopener">cites</a> familiar sources. The notice reportedly takes effect next week.
Mainland China contributed 11% to Taiwan Semiconductor&#8217;s third-quarter revenue, whereas North America accounted for 71%, SCMP cites Visible Alpha by S&amp;P Global Market Intelligence data.
Taiwan Semiconductor posted <a target="_blank" href="https://www.benzinga.com//node/41373163" rel="noreferrer noopener">fiscal third-quarter revenue</a> of 759.69 billion New Taiwan dollars ($23.50 billion), marking a 39% increase and surpassing both its guidance range of $22.4 billion—$23.2 billion and analyst expectations.
The company credited strong demand for smartphones and AI applications, driven by its advanced 3nm and 5nm technologies, with Needham&#8217;s Charles Shi noting <a target="_blank" href="https://www.benzinga.com/news/24/10/41388050/apples-3nm-push-boosts-taiwan-semis-q3-ai-revenue-set-to-triple-analyst" rel="noreferrer noopener">Apple as a key contributor</a>. Gross margin widened by 350 basis points to 57.8%. For the fourth quarter, Taiwan Semiconductor projects revenue of $26.1 billion—$26.9 billion, exceeding the Street&#8217;s forecast of $24.86 billion.
Taiwan Semiconductor stock gained over 98% year-to-date.
Price Actions: TSM stock is up 2.60% at $206.43 premarket at the last check on Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41819699/roblox-tightens-safety-bans-preteens-from-virtual-social-spaces" target="_blank" rel="noreferrer noopener">Roblox Tightens Safety, Bans Preteens from Virtual Social Spaces</a></li>
</ul>
Image via Shutterstock

Government

Regulations

Movers

Tech

Media

AAPL

NVDA

Taiwan Semiconductor US Expansion Plans Unfazed by Trump Win: Report

Truist Securities analyst Michael Swartz maintains Acushnet Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLF#NYSE">GOLF</a>) with a Hold and raises the price target from $65 to $68.

GOLF

Truist Securities Maintains Hold on Acushnet Hldgs, Raises Price Target to $68

SKYE

Skye Bioscience shares are trading higher after the company reported better-than-expected Q3 EPS results.

Benchmark analyst Daniel Kurnos maintains Tegna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGNA#NYSE">TGNA</a>) with a Buy and raises the price target from $21 to $23.

TGNA

Benchmark Maintains Buy on Tegna, Raises Price Target to $23

PSTX

Poseida Therapeutics shares are trading higher after the company reported better-than-expected Q3 financial results.

Scotiabank analyst Mario Saric maintains Killam Apartment REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/KMP#TSX">KMP</a>) with a Sector Perform and raises the price target from C$20.5 to C$21.

TSX:KMP

TSX:KMP/UN

Scotiabank Maintains Sector Perform on Killam Apartment REIT, Raises Price Target to C$21

Truist Securities analyst Neal Dingmann maintains APA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>) with a Buy and lowers the price target from $36 to $33.

Truist Securities Maintains Buy on APA, Lowers Price Target to $33

Chainlink (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/link/usd">LINK</a>) co-founder Sergey Nazarov on Friday said &#8220;the party&#8217;s back on&#8221; for cryptocurrency markets, predicting substantial industry growth amid potential changes in the U.S. regulatory <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41823388/the-trump-effect-a-deep-dive-into-how-the-crypto-landscape-will-change-in-2025-and-beyond">landscape under Donald Trump&#8216;s presidency</a>.
What Happened: &#8220;This is just the beginning basically. This is like the party&#8217;s back on and there&#8217;s going to be huge huge growth in all categories of crypto,&#8221; Nazarov <a href="https://x.com/ChainLinkGod/status/1854553832396828796">told</a> CNBC, expressing optimism about the industry&#8217;s trajectory.
Nazarov emphasized that cryptocurrency&#8217;s fundamental benefits to society outweigh regulatory concerns. 
&#8220;I think that crypto fundamentally benefits society and makes things work in a much more reliable way than they do now,&#8221; he stated, citing <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41654131/pro-crypto-congress-in-2025-experts-see-stablecoins-as-key-area-for-advancement">stablecoins</a> and tokenized funds as examples of successful implementation.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41841793/bitcoin-ethereum-solana-rally-does-not-mean-all-cryptocurrencies-will-moon-10x-research">Bitcoin, Ethereum, Solana Rally Does Not Mean All Cryptocurrencies Will Moon: 10x Research</a>
Drawing parallels with Asian crypto hubs, Nazarov pointed to successful regulatory frameworks in <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40901724/singapores-dbs-bank-launches-bitcoin-and-ethereum-options-trading-for-institutional-client">Singapore</a> and Hong Kong.
&#8220;More regulation doesn&#8217;t mean better markets, it just means kind of muted markets with less innovation,&#8221; he explained, advocating for a more permissive approach to <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41823388/the-trump-effect-a-deep-dive-into-how-the-crypto-landscape-will-change-in-2025-and-beyond">cryptocurrency regulation</a>.
Price Action: Chainlink has followed other cryptocurrencies&#8217; uptrend since the start of October.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Price</td>
<td>1-day performance</td>
<td>7-day performance</td>
<td>30-day performance</td>
</tr>
<tr>
<td>$13.32</td>
<td>+8.6%</td>
<td>+14.7%</td>
<td>+25.6%</td>
</tr>
</tbody>
</table>
</figure>
The Chainlink co-founder&#8217;s perspectives align with growing institutional interest in digital assets, a topic that will be further explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41814454/donald-trump-could-pardon-ross-ulbricht-january-6-protestors-and-one-other-controversial-f">Donald Trump Could Pardon Ross Ulbricht, January 6 Protestors And One Other Controversial Figure, Polymarket Traders Speculate</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$LINK

'The Party's Back On'—Chainlink Co-Founder Predicts Major Crypto Growth Under Trump Presidency

EXFY

Expensify shares are trading higher after the company reported better-than-expected Q3 financial results.

Baxter International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAX#NYSE">BAX</a>) reported a third-quarter 2024 adjusted EPS of 80 cents, beating the management guidance of 77 cents to 79 cents and the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">Wall Street estimate of 78 cents</a>.
This was driven by top-line strength in Medical Products &amp; Therapies and Kidney Care, continued improvements in the integrated supply chain, and disciplined operating expense management.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/10/41403928/us-hospitals-face-critical-iv-fluid-shortage-after-baxter-facility-shuts-down-due-to-hurricane-hel" rel="noreferrer noopener">US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene</a>
The Deerfield, Illinois-based company reported sales of $3.85 billion, in line with consensus.
Baxter&#8217;s worldwide sales include continuing sales of $2.69 billion and discontinued operations (kidney care) <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41840934/baxter-reports-third-quarter-2024-results" rel="noreferrer noopener">sales of $1.15 billion</a>.
Excluding Q3 2023 BioPharma Solutions (BPS) sales and including sales of Kidney Care in both periods, worldwide Baxter sales grew 4% on both a reported and constant currency basis, in line with the company&#8217;s prior guidance.
Adjusted EPS from continuing operations was 49 cents, up 14% year-over-year.
Revenue from Medical Products &amp; Therapies increased 7% to $1.34 billion, Healthcare Systems &amp; Technologies sales increased 1% to $752 million, and Pharmaceuticals sales were up 1% to $588 million.
Last week, Baxter said it has restarted North Cove&#8217;s highest-throughput IV solutions manufacturing line.
At its peak operation (before Hurricane Helene), this line represented approximately 25% of the site&#8217;s total production and approximately 50% of the site&#8217;s production of one-liter IV solutions, the most commonly used size by hospitals and clinics.
Baxter&#8217;s current expectation is that new product from North Cove could begin shipping to distributors and customers by the end of November, ahead of its original expectations.
Guidance: &#8220;While the hurricane&#8217;s aftermath is expected to have an impact on our near-term financial outlook, we remain confident in Baxter&#8217;s outlook and growth trajectory following completion of the pending Kidney Care sale,&#8221; said José (Joe) Almeida, chair, president &amp; CEO.
Baxter expects fourth-quarter adjusted EPS of 77 cents to 81 cents, with 50 cents to 53 cents expected from continuing operations.
For the fourth quarter, the company forecasts sales from continuing operations to decline in low-single digits on a reported and constant currency basis.
For fiscal year 2024, Baxter sees adjusted EPS of $2.90-$2.94 compared to a consensus of $2.95 and <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40191263/baxter-lifts-annual-outlook-after-strong-q2-beat-medical-devices-sales" rel="noreferrer noopener">prior guidance of $2.93-$3.01</a>, including $1.81-$1.84 from continuing operations.
The company <a target="_blank" href="https://s22.q4cdn.com/911189824/files/doc_financials/2024/q3/Baxter_Reports_Third-Quarter_2024_Results_Presentation.pdf" rel="noreferrer noopener">expects</a> sales (from continuing operations) growth of around 2%.
Baxter anticipates a full-year 2025 adjusted operating margin of approximately 16.5% on a continuing operations basis, which reflects an anticipated 100 basis point negative impact due to stranded costs. The company expects to offset these stranded costs in 2027.
Price Action: BAX stock is down 1.22% at $35.60 during the premarket session at last check Friday.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41843534/astrazeneca-amgens-asthma-drug-aces-late-stage-study-in-patients-with-chronic-rhinosinusitis" target="_blank" rel="noreferrer noopener">AstraZeneca/Amgen&#8217;s Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis</a></li>
</ul>
Image: Shutterstock

Guidance

Health Care

General

Baxter Expects Hurricane Helene Aftermath To Impact Near-Term Financial Outlook

Truist Securities analyst Tobey Sommer maintains AMN Healthcare Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMN#NYSE">AMN</a>) with a Buy and lowers the price target from $50 to $47.

Truist Securities Maintains Buy on AMN Healthcare Services, Lowers Price Target to $47

Barclays raised the firm's price target on Viking Holdings (VIK) to $43 from $39 and keeps an Overweight rating on the shares as part of a Q3 earni...

Viking Holdings price target raised to $43 from $39 at Barclays

Barclays analyst Brandt Montour maintained a Buy rating on Viking Holdings Ltd (VIK – Research Report) today and set a price target of $43.00. The ...

Viking Holdings Ltd (VIK) Receives a Buy from Barclays

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Viking Holdings (NYSE:<a href="https://investorplace.com/stock-quotes/vik-stock-quote/">VIK</a>) just reported results for the second quarter of 2024.<ul><li>Viking Holdings reported earnings per share of 37 cents. This was below the analyst estimate for EPS of 65 cents.</li><li>The company reported revenue of $1.59 billion.</li><li>This was 10.98% better than the analyst estimate for revenue of $1.43 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	The post <a href="https://investorplace.com/earning-results/2024/08/vik-stock-earnings-viking-holdings-for-q2-of-2024/">VIK Stock Earnings: Viking Holdings Misses EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VIK Stock Earnings: Viking Holdings Misses EPS, Beats Revenue for Q2 2024

Catalyst Watch: Eyes on tech with Apple, Amazon, Alphabet, and Meta reporting

IPO Roundup: Brazil Potash, Septerna and more

Royal Caribbean Q4 guidance reflects impact from Hurricane Milton

The Momentum Weekly - On The Cusp Of The Election

ACTHF

AMZN

BMEA

CAKR

CASK

CHTR

CUPR

DASH

DUOL

FBGL

FFIV

FMFC

FUTU

FVRR

GELS

GOOG

HSBC

IDCC

INGM

INTC

INUV

LFVN

LMND

MGPI

MRNS

MSFT

NCLH

OSTX

PAPL

PHUN

PTON

QRVO

RBLX

RDDT

RKLB

RMLFF

SABR

SAVE

SBUX

SNAP

SVCO

TDACU

TLTFF

TSLA

UBER

WHLR

XPEV

Press Releases

Viking Takes Delivery of Newest Egypt Ship

Viking Reports Second Quarter 2024 Financial Results

Viking Announces Expansion of China Offering with New Voyages Starting in 2025

Viking Announces Launch of Secondary Public Offering

Viking Announces Pricing of its Secondary Offering

Viking Celebrates Historic Return to China

Condé Nast Traveler Readers Name Viking #1 for Rivers, #1 for Oceans and #1 for Expeditions for Second Consecutive Year

Viking Schedules Conference Call on Third Quarter 2024 Financial Results

Viking Names Two Newest Nile River Ships in Luxor

Airbnb

Atour Lifestyle Holdings Limited - American Depositary Shares

Atour Lifestyle Holdings

Booking Holdings

Choice Hotels International, Inc. Common Stock

Choice Hotels Intl

Despegar.com

Expedia Group

Global Business Travel Group, Inc. Class A Common Stock

Global Business Travel

GreenTree Hospitality Group Ltd. American depositary shares, each representing one Class A ordinary share

GreenTree Hospitality Gr

Hyatt Hotels Corporation Class A Common Stock

Hyatt Hotels

Hilton Grand Vacations

Hilton Worldwide Holdings Inc. Common Stock

Hilton Worldwide Holdings

H World Group Limited - American Depositary Shares

H World Group

Intercontinental Hotels Group American Depositary Shares (Each representing one Ordinary Share)

Comments

Viking Holdings

Notizie

Ultime notizie per Viking Holdings (NYSE:VIK) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO